Literature DB >> 33137342

DNA methylation associated with persistent ADHD suggests TARBP1 as novel candidate.

Annika L Weiß1, Mandy Meijer2, Bettina Budeus3, Marc Pauper2, Marina Hakobjan2, Johanne Groothuismink2, Yan Shi2, Kornelia Neveling2, Jan K Buitelaar4, Martine Hoogman2, Barbara Franke5, Marieke Klein6.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention and/or hyperactivity and impulsivity. ADHD is highly prevalent in childhood and often persists into adulthood. Both genetic variants and environmental factors play a role in the onset and persistence of ADHD, and epigenetic changes, such as DNA methylation are considered as a link for their interplay. To investigate this, we studied DNA methylation in 37 candidate genes by performing targeted bisulfite sequencing of DNA isolated from whole blood of N = 88 individuals diagnosed with adult ADHD and N = 91 unaffected individuals (mean age 34.2 years). Differentially methylated sites were assessed by generalized linear models testing ADHD status and ADHD symptoms, accounting for a methylation-based smoking score, age, sex, and blood cell count. DNA methylation of single sites within DRD4 and KLDR1 was associated with adult ADHD status, and multiple DNA methylation sites within TARBP1 were associated with ADHD symptoms in adulthood and childhood. Awaiting replication, findings of this pilot study point to TARBP1 as a new candidate gene for ADHD symptoms. Our work also stresses the need for research to further examine the effects of environmental factors, such as nicotine exposure, on epigenetic modifications associated with psychiatric traits.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  ADHD; DNA methylation; Epigenetics; Max. 6; Neurodevelopmental disorder; Smoking; TARBP1

Year:  2020        PMID: 33137342     DOI: 10.1016/j.neuropharm.2020.108370

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Epigenetics and ADHD.

Authors:  Timothy Silk; Lillian Dipnall; Yen Ting Wong; Jeffrey M Craig
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Genetic Variations in Elements of the Oxytocinergic Pathway are Associated with Attention/Hyperactivity Problems and Anxiety Problems in Childhood.

Authors:  Laísa Camerini; Gabriel Zurchimitten; Bertha Bock; Janaína Xavier; Clarissa Ribeiro Bastos; Evânia Martins; Ana Paula Ardais; Janaína Vieira Dos Santos Motta; Andressa Jacondino Pires; Mariana Bonati de Matos; Luciana de Ávila Quevedo; Ricardo Tavares Pinheiro; Gabriele Ghisleni
Journal:  Child Psychiatry Hum Dev       Date:  2022-09-10

Review 3.  Integrating Psychiatry and Medical Biotechnology as a Way to Achieve Scientific, Precision, and Personalized Psychiatry.

Authors:  Ahmad Shamabadi; Alireza Hasanzadeh; Shahin Akhondzadeh
Journal:  Avicenna J Med Biotechnol       Date:  2021 Oct-Dec

Review 4.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.